We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
-4.03%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$2.17B
AUM Growth
-$6.39M
(-0.29%)
Cap. Flow
+$112M
Cap. Flow
% of AUM
5.15%
Top 10 Holdings %
Top 10 Hldgs %
36.67%
Holding
3,684
New
390
Increased
1,387
Reduced
1,049
Closed
222
Avg Time Held Equity + Options
3.1
years
Top 10 Avg Time Held Equity + Options
2.1
years
Top 20 Avg Time Held Equity + Options
2
years
Avg Time Held Equity only
3.1
years
Top 10 Avg Time Held Equity only
2.1
years
Top 20 Avg Time Held Equity only
2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares International Select Dividend ETF
IDV
|
+$42.9M |
| 2 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$36.8M |
| 3 |
Corcept Therapeutics
CORT
|
+$28.1M |
| 4 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$20.3M |
| 5 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$18.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI USA Value Factor ETF
VLUE
|
+$24.4M |
| 2 |
iShares Core US REIT ETF
USRT
|
+$23.7M |
| 3 |
State Street Blackstone Senior Loan ETF
SRLN
|
+$21.7M |
| 4 |
iShares Core S&P Small-Cap ETF
IJR
|
+$17.5M |
| 5 |
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
|
+$12.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 51.55% |
| 2 | Technology | 12.45% |
| 3 | Healthcare | 9.68% |
| 4 | Financials | 8.7% |
| 5 | Consumer Discretionary | 4.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3051
AH Realty Trust
AHRT
$445M
| – | – |
-26
| Closed | – | – |
|
3052
Applied Industrial Technologies
AIT
$12.1B
| – | – |
-7
| Closed | -$1K | – |
|
3053
Alector
ALEC
$211M
| $0 | ﹤0.01% |
15
-32
| -68% | -$346 |
2021 Q1
6 quarters
|
|
3054
Alexander's
ALX
$1.18B
| $0 | ﹤0.01% |
1
| – | – |
2022 Q2
1 quarter
|
|
3055
Amphastar Pharmaceuticals
AMPH
$1.09B
| $0 | ﹤0.01% |
13
-6
| -32% | -$196 |
2021 Q3
4 quarters
|
|
3056
Amneal Pharmaceuticals
AMRX
$6.64B
| $0 | ﹤0.01% |
+60
| New | +$168 |
2022 Q3
0 quarters
|
|
3057
Amerant Bancorp
AMTB
$1.14B
| – | – |
-6
| Closed | – | – |
|
3058
American Well
AMWL
$195M
| – | – |
-4
| Closed | – | – |
|
3059
Alpha and Omega Semiconductor
AOSL
$676M
| – | – |
-12
| Closed | -$444 | – |
|
3060
American Outdoor Brands
AOUT
$229M
| – | – |
-34
| Closed | -$289 | – |
|
3061
Algonquin Power & Utilities
AQN
$4.03B
| $0 | ﹤0.01% |
31
+23
| +288% | +$312 |
2022 Q1
2 quarters
|
|
3062
Arcturus Therapeutics
ARCT
$297M
| $0 | ﹤0.01% |
17
| – | – |
2021 Q1
6 quarters
|
|
3063
Arcutis Biotherapeutics
ARQT
$3.56B
| – | – |
-7
| Closed | – | – |
|
3064
DELISTED
AtaiBeckley Inc
ATAI
| $0 | ﹤0.01% |
100
| – | – |
2022 Q1
2 quarters
|
|
3065
A10 Networks
ATEN
$1.77B
| $0 | ﹤0.01% |
+17
| New | +$242 |
2022 Q3
0 quarters
|
|
3066
Atlanticus Holdings
ATLC
$1.41B
| – | – |
-11
| Closed | – | – |
|
3067
Atara Biotherapeutics
ATRA
$95.5M
| $0 | ﹤0.01% |
+4
| New | +$449 |
2022 Q3
0 quarters
|
|
3068
Atlantic Union Bankshares
AUB
$5.42B
| $0 | ﹤0.01% |
+14
| New | +$472 |
2022 Q3
0 quarters
|
|
3069
Aurora
AUR
$10.1B
| $0 | ﹤0.01% |
180
+150
| +500% | +$371 |
2021 Q3
4 quarters
|
|
3070
Mission Produce
AVO
$1.05B
| $0 | ﹤0.01% |
+19
| New | +$290 |
2022 Q3
0 quarters
|
|
3071
AvePoint
AVPT
$3B
| $0 | ﹤0.01% |
49
+3
| +7% | +$14 |
2022 Q2
1 quarter
|
|
3072
Avalo Therapeutics
AVTX
$616M
| – | – |
0
| – | – |
2020 Q1
10 quarters
|
|
3073
AXIS Capital
AXS
$7.19B
| – | – |
-12
| Closed | -$1K | – |
|
3074
Invesco Taxable Municipal Bond ETF
BAB
$855M
| $0 | ﹤0.01% |
16
| – | – |
2018 Q4
15 quarters
|
|
3075
Banc of California
BANC
$2.72B
| – | – |
-10
| Closed | – | – |
|
Similar funds
Parallel Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, Parallel Advisors held 3,684 positions worth $2.17B, down 0.29% from $2.18B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Parallel Advisors deployed $112M of net new capital in Q3 2022, opening 390 new positions and adding to 1,387 existing holdings. Its largest new stake was iShares MSCI USA Equal Weighted ETF: 17,208 shares worth $1.15M.
By sector, the portfolio is most concentrated in Miscellaneous at 52% of assets, down from 52% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was iShares MSCI USA Value Factor ETF, an estimated $24.4M trimmed.
- Parallel Advisors's largest Q3 2022 buy was iShares MSCI USA Equal Weighted ETF: 17,208 shares worth $1.15M.
- Parallel Advisors added most to iShares International Select Dividend ETF in Q3 2022, an estimated $42.9M increase.
- Parallel Advisors's biggest Q3 2022 reduction was iShares MSCI USA Value Factor ETF, cutting an estimated $24.4M.
- Parallel Advisors fully exited Sanderson Farms Inc in Q3 2022, selling an estimated $503K.
- Parallel Advisors's ten largest holdings make up 37% of its $2.17B portfolio in Q3 2022.
- Parallel Advisors opened 390 new positions and closed 222 in Q3 2022.
- Parallel Advisors's portfolio value fell 0.29% quarter-over-quarter to $2.17B.
Based on Parallel Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.